UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (date of earliest event reported): August 5, 2008
PEDIATRIX
MEDICAL GROUP, INC.
(Exact
Name of Registrant as Specified in Its Charter)
Florida |
001-12111 |
65-0271219 |
||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number)
|
(IRS Employer Identification No.)
|
1301 Concord Terrace Sunrise, Florida 33323 |
|
|
(Address of principal executive offices) (zip code) |
|
Registrant’s
telephone number, including area code
(954) 384-0175
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
2.02 Results of Operations and Financial Condition.
On August 5, 2008, Pediatrix Medical Group, Inc. (the “Company”) issued a press release announcing its results of operations for the three and six months ended June 30, 2008 (the “Release”). A copy of the Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the Securities and Exchange Commission nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
99.1—Press
Release of Pediatrix Medical Group, Inc. dated August 5, 2008.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PEDIATRIX MEDICAL GROUP, INC. |
|||
|
|||
Date: | August 5, 2008 | By: |
/s/ Karl B. Wagner |
Name: Karl B. Wagner |
|||
Title: Chief Financial Officer |
EXHIBIT INDEX
Exhibit No. |
Description |
99.1 |
Press Release of Pediatrix Medical Group, Inc. dated August 5, 2008. |